期刊文献+

白细胞介素-6与甲状腺疾病 被引量:3

Interleukin-6 and thyroid disease
原文传递
导出
摘要 白细胞介素-6(IL-6)是一种多功能的细胞因子,参与细胞多种生物功能。IL-6的跨膜信号转导主要分为两种,即经典通路和反式信号通路,通过IL-6/酪氨酸激酶-1(JAK-1)/信号转导和转录激活因子-3(STAT-3)途径发挥其生物学作用。研究发现,IL-6能够抑制甲状腺细胞的分泌功能及摄碘功能。其次,在临床中发现,IL-6水平升高不仅与Graves病、桥本甲状腺炎显著相关,而且IL-6基因多态性与Graves病及桥本甲状腺炎的发病关系密切。另外,研究发现,IL-6在甲状腺癌的发病机制中亦扮演重要的角色。 Interleukin(IL)-6 is a multifunctional cytokine involved in multiple biological functions of cells. Transmembrane signaling of IL-6 is divided into two types, the classical pathway and the trans-signaling pathway, and it plays biological effect via IL-6/Janus kinase-1 (JAK1)/signal transducers and activators of transcription-3 ( STAT3 ) signal pathway. The study found that IL-6 could inhibit the secretion of thyroid cells and iodine uptake function. Secondly, clinical study found that the level of IL-6 was increased significantly in Graves' disease and Hashimoto's thyroiditis, and IL-6 geue poiymorphism was closely related with Graves' disease and Hashimoto's thyroiditis. In addition, IL4 also plays an important role in the patho- genesis of thyroid eareinoma.
作者 郑仁东 刘超
出处 《国际内分泌代谢杂志》 2016年第5期352-354,共3页 International Journal of Endocrinology and Metabolism
关键词 白细胞介素-6 GRAVES病 桥本甲状腺炎 甲状腺癌 Interleukin-6 Graves' disease Hashimoto's thyroiditis Thyroid carcinoma
  • 相关文献

参考文献26

  • 1Ataie-Kachoie 17, Pourgholami MH, Richardson DR, et al. Gene of the month: interleukin 6 (IL-6) [J]. J Clin Pathol,2014,67 ( 11 ) :932-937. DOI: 10. 1136/jclinpath-2014-202493.
  • 2Rossi JF, Lu ZY, Jourdan M, et al. Interleukin-6 as a therapeu- tic target[J]. Clin Cancer Res,2015,21 (6) :1248-1257. DOI: 10. 1158/1078-0432. CCR-14-2291.
  • 3Chang Q, Daly L, Bromberg J. The IL-6 feed-forward loop: a driver of tumorigenesis [ J ]. Semin Immunol, 2014,26 ( 1 ) : 48- 53. DOI: 10. 1016/j. smim. 2014.01. 007.
  • 4Wolf J, Rose-John S, Garbers C. Interleukin-6 and its receptors: a highly regulated and dynamic system [ J ]. Cytokine, 2014,70 (1) :11-20. DOI: 10. 1016/j. cyto. 2014.05.024.
  • 5Ernst M, Thiem S, Nguyen PM, et al. Epithelial gpl30/Stat3 functions: an intestinal signaling node in health and disease[ J ]. Semin Immunol, 2014,26 ( 1 ) :29-37. DOI: 10. 1016/j. smim. 2013.12. 006.
  • 6Yamazaki K, Yamada E, Kanaji Y,et al. lnterleukin45 (IL-6) inhibits thyroid function in the presence of soluble IL-6 receptor in cultured human thyroid follicles[ J]. Endocrinology, 1996,137 ( 11 ) :4857-4863.
  • 7Lumachi F, Basso SM, Orlando R. Cytokines, thyroid diseases and thyroid cancer[ J ]. Cytokine, 2010,50 ( 3 ) : 229-233. DOI : 10. 1016/j. cyto. 2010.03. 005.
  • 8Nielsen CH, Brix TH, Leslie RG, et al. A role for autoantibodies in enhancement of pro-inflammatory cytokine responses to a self- antigen, thyroid peroxidase [ J ]. Clin Immunol, 2009,133 ( 2 ) : 218-227. DOI: 10. 1016/j. clim. 2009.07. 014.
  • 9Lacka K, Maciejewski A. Current views on the etiopathogenesis of autoimmune thyroiditis ( Hashimoto' s disease) [ J ]. Pol Merkur Lekarski ,2011,30 (176) : 132-138.
  • 10Lumachi F, Basso SM, Orlando R. Cytokines, thyroid diseases and thyroid cancer[ J ]. Cytokine, 2010,50 ( 3 ) : 229-233. DOI : 10. 1016/j. cyto. 2010.03.005.

二级参考文献45

  • 1伍石华.甲状腺肿瘤组织中VEGF及其受体表达与临床病理的联系[J].临床肿瘤学杂志,2006,11(5):371-372. 被引量:6
  • 2侯健 王东星 胥军民.人类细胞因子手册[M].上海:同济大学出版社,1995.153.
  • 3中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. 被引量:846
  • 4Jacobson EM, Tomer Y. The genetic basis of thyroid autoimmunity [ J]. Thyroid ,2007,17 (lO) 949-961.
  • 5Lantz M, Planck T, Asman P, et al. Increased TRAb and/or low anti-TPO titers at diagnosis of graves'disease are associated with an increased risk of developing ophthalmopathy after onset [ J ]. Exp Clin Endocrinol Diabetes ,2014,122 ( 2 ) : 113-117.
  • 6Esfahanian F, Naimi E, Doroodgar F, et al. Thl/Th2 cytokines in patientswith Graves'disease with or without ophthalmopathy [ J ] Iran J Allergy Asthmalmmunol,2013,12(2) :168-175.
  • 7Peng D,Xu B,Wang Y,et al. A high frequency of circulating th22 and thl7 cells in patients with new onset graves'disease[ J]. PLoS One,2013,8(7) :e68446.
  • 8Yamamoto K, Itoh M, Okamura T, et al. Relative levels of the in- flammatory cytokine TNFα and the soluble CD40 ligand profile in serum correlate with the thyrotoxic activity of Graves'disease [ J ]. Thyroid ,2012,22 ( 5 ) :516-521.
  • 9Zhou J,Bi M,Fan C,et al. Regulatory T cells but not T helper 17 ceils are modulated in an animal model of Graves'hyperthyroidism [ J ]. Clin Exp Med ,2012,12 ( 1 ) :39-46.
  • 10Inoue A, Koizumi S, Matsuda A, et (tl. Graves' hyperthyroidism showing transient hypothyroidism during interferon therapy for chronic hepatitis type C [ J ]. Endocr J,2005,52 ( 3 ) :293 -298.

共引文献45

同被引文献39

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部